loader image

Changing the world
one smile at a time

Changing the world one smile at a time

AME Healthcare is a regional healthcare group dedicated to
promoting oral health in Asia and the Middle East (AME).

AME Healthcare is a regional healthcare group dedicated to promoting oral health in Asia and the Middle East (AME).

Clinics
0 +
Countries
0 +
Dentists
0 +
of Smiles
0 s

About AME Healthcare

AME Healthcare is a regional healthcare group dedicated to promoting oral health in Asia and the Middle East (AME). We offer every patient the finest treatment possible through integrated clinical practices and technology, inspiring confidence and contributing to their dental health and overall wellbeing.

About My Dentist

AME Healthcare is the holding company for the My Dentist chain of state-of-the-art dental clinics, currently operating in Sri Lanka and the United Arab Emirates. We are continuing to grow our network with expansion plans already underway in Bangladesh and the Maldives.

Our Products & Services

EasyDental – Clinic Management Software

Utilize EasyDental Software to expand your clinic clientele and financial success with Simple, Cohesive Tools. To overcome today’s problems, you need proven, integrated technology that streamlines business administration so you can focus on patients as a dentist.

EasyHealth – Virtual Personal Health Assistance Services

We’re on a mission to make access to healthcare services more straightforward and intuitive by combining data, design, and a lot of empathy.

Think of EasyHealth as your personal assistant in matters relating to accessing healthcare services. EasyHealth has stitched together a network of doctors, hospitals, healthcare providers, pharmacies, and insurance companies to serve up an array of options to those seeking diagnostic and other non-emergency healthcare services.

 

Take control of your dental health - Contact us now !

Our values and ESG

We believe that access to decent healthcare is a basic human need. The entire team at AME Healthcare strives every day to bring world-class, affordable and effective oral health solutions to the markets in which we operate.

Our approach focuses on two areas – improving access to oral healthcare and strengthening communities.

Our clinics are not only located in major cities and many are, in fact, in suburban and rural areas. In keeping with our commitment to community medicine, we provide free oral health checkups to school children and at-risk patients. We also work with disadvantaged groups within the broader community to bring them access to quality, affordable oral healthcare.

 

Board of Directors

MICHEL CASSELMAN
ASANTH SEBASTIAN
SHARAD SRI
PROF. GEORGE JAYANTHA DIAS
MICHEL CASSELMAN

Michel Casselman is general manager of PMV. Before taking over at the helm at PMV, Michel Casselman was a Partner at Aeroman, which manages private equity investments in aviation equipment. Michel Casselman also worked 13 years at Petercam Bank NV, where he started in 1998 as a financial analyst and held various positions. During his last position as a director of Petercam Services, he was responsible for private equity investments. In this role, he managed or invested directly in aviation and renewable energy, as well as in listed private equity funds in Asia (China, India, and Vietnam). Michel Casselman has more than 20 years of experience, five of which were at a technology company, now part of Oracle Corporation, where he started as a consultant and retired as Director of Consulting Services. He holds two master’s degrees from the KU Leuven, one as a Mechanical Engineer, and one in Applied Economics. Michel Casselman also completed further studies at Kellogg’s University in the United States and at INSEAD in France.

 

ASANTH SEBASTIAN

Asanth Sebastian co-founded Ataraxia Capital, is a member of its Board of Directors, and serves on the Investment Committee. He is jointly responsible for leading the investment program at Ataraxia, and also has overall co-executive responsibility for the firm. Asanth heads all the investment teams across Australia (ACP Corum), Singapore (SOF), and Sri Lanka (Arpico Ataraxia). He serves on the Board and oversees the audit and finance committees of all investee companies. His focus more recently has been on the expansion of the investor universe into China and Europe. Asanth has direct operational experience, having performed interim management roles in Ataraxia portfolio companies with a specific focus on effecting management and business improvement initiatives. Prior to founding Ataraxia, he worked at the structured product desk of UBS, and post that in a management position in equities and structured products at the Australian Stock Exchange. Asanth wrote the course material for the ASX-accredited Derivatives Adviser (ADA), and the ASX-accredited Listed Product Adviser courses (ALPA) that are the industry standards for financial services professionals in Australia. Asanth holds a Finance and Economics Degree from Macquarie University.

 

SHARAD SRI

Sharad Sri co-founded Ataraxia Capital, is a member of its Board of Directors, and serves on the Investment Committee. He is jointly responsible for leading the investment program at Ataraxia, and also has overall co-executive responsibility for the firm. Sharad is responsible for overseeing all investments and investment decisions across the markets in which Ataraxia operates. His focus in the last few years has been on the expansion of Ataraxia into new markets with the launch of ACP Corum in Australia and other collaborations in Europe and beyond. He serves on all investee company boards and maintains strong personal relationships with all stakeholders across the investment spectrum. Prior to founding Ataraxia, Sharad trained and practiced as a corporate M&A lawyer in both Sydney and Abu Dhabi, and has worked for several premier law firms, including Linklaters, Allen’s Arthur Robinson, and DLA Piper. He has advised numerous governments, including the Government of Abu Dhabi and the Government of Timor-Leste in setting up and managing strategic investment vehicles across real estate, infrastructure, and film finance. He holds Bachelor of Business and Juris Doctorate degrees from the University of Technology, Sydney.

 

PROF. GEORGE JAYANTHA DIAS

Professor in Clinical Anatomy & Biomaterials, Department of Anatomy, School of Biomedical Sciences, University of Otago, New Zealand.

Prof. George J Dias is an internationally recognized researcher and teacher. His primary research focus is in the area of biomaterials for: formulating smart bioactive toothpaste for 21st century dentistry; implantable scaffolds for bone regeneration; biodegradable magnesium alloy-based surgical devices; extracting novel edible protein from nontraditional sources. He is also a reputed surgical/clinical anatomy teacher in both undergraduate and postgraduate professional courses. The basis of the above attributes stems from his 16 years’ experience in clinical dentistry and oral & maxillofacial surgery, which led him to take up academia at the University of Otago (1999). He has published extensively in clinical anatomy, paleopathology, and biomaterials. He has 91 publications, including 4 patents, 7416 citations, and a h-index of 29. His current focus is translational research related to bioactive ceramics for oral hygiene, degradable natural polymeric bone substitute, and dental tissue regeneration materials; magnesium-based biodegradable orthopaedic devices; bioactive hydroxyapatite for bone regeneration; absorbable suture materials with wound healing properties; and extraction of premium edible protein from keratinous raw material.